<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36215047</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2222-1751</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Emerging microbes &amp; infections</Title><ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation></Journal><ArticleTitle>Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study.</ArticleTitle><Pagination><StartPage>2680</StartPage><EndPage>2688</EndPage><MedlinePgn>2680-2688</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2022.2133639</ELocationID><Abstract><AbstractText>The long-term effect of coronavirus disease 2019 (COVID-19) has been rarely known. This study aimed to investigate healthy outcomes of COVID-19 survivors up to 2 years after the infection. A total of 155 COVID-19 patients, who were discharged from Shenzhen Third People's Hospital from February 2020 to April 2020, were enrolled and followed up until March 4, 2022. COVID-19 survivors received questionnaires of long COVID symptoms and psychological symptoms, pulmonary function tests, chest computed tomography (CT) scans and routine laboratory tests. Two years after infection, 36.6% of patients had at least one symptom of long COVID. Vision impairment and fatigue were the most common symptom. 35.0% of participants still had at least one psychological symptom of anxiety, depression, post-traumatic stress symptoms, and sleep difficulties. Radiographic abnormalities were presented in 50.7% of patients, with the most common features of fibrosis-like lesions and residual ground-glass opacity. Diffuse dysfunction (24.0%) was the main abnormalities of pulmonary function tests. Most laboratory parameters returned to normal range, while persistent abnormalities in kidney and liver function test were observed in a subset of participants after discharge. Two years after COVID-19 infection, persistent symptoms of long COVID and psychological symptoms, as well as abnormalities in pulmonary function tests and CT, were still common in a subset of recovering individuals. These findings were limited by the lack of a healthy control group and pre-COVID assessments, which should be confirmed by further large-scale studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dapeng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Xuejiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Zhenghua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Jingke</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Guoqin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zi</LastName><ForeName>Mei</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0488-8433</Identifier><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Guobao</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Research Center for Communicable Disease Diagnosis and Treatment of Chinese Academy of Medical Science, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Key Laboratory for Anti-infection Drug Quality Evaluation, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital; The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Research Center for Communicable Disease Diagnosis and Treatment of Chinese Academy of Medical Science, Shenzhen, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Microbes Infect</MedlineTA><NlmUniqueID>101594885</NlmUniqueID><ISSNLinking>2222-1751</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">follow-up</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>10</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36215047</ArticleId><ArticleId IdType="pmc">PMC9639507</ArticleId><ArticleId IdType="doi">10.1080/22221751.2022.2133639</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO . WHO coronavirus disease (COVID-19) dashboard.</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022 Apr;22(4):e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, et al. . Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. Br Med J. 2021 Jan 22;372(n136).</Citation><ArticleIdList><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. . Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Network Open. 2021 Oct 1;4(10):e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. . 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021 Aug 28;398(10302):747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Tao M, Shang L, et al. . Assessment of sequelae of COVID-19 nearly 1 year after diagnosis. Front Med (Lausanne). 2021;8:717194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8649686</ArticleId><ArticleId IdType="pubmed">34888318</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EL, Gossling A, Adam G, et al. . Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg city health study COVID programme. Eur Heart J. 2022 Mar 14;43(11):1124&#x2013;1137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Seessle J, Waterboer T, Hippchen T, et al. . Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): A prospective cohort study. Clin Infect Dis. 2022 Apr 9;74(7):1191&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Izquierdo M, Lainez-Ramos-Bossini AJ, de Alba IG, et al. . Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes &#x2013; a multicentre cohort study. BMC Med. 2022 Feb 23;20(1):92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863509</ArticleId><ArticleId IdType="pubmed">35193574</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Wu D, Yan W, et al. . Twelve-Month systemic consequences of coronavirus disease 2019 (COVID-19) in patients discharged from hospital: A prospective cohort study in Wuhan, China. Clin Infecti Dis. 2022 Jun 10;74(11):1953&#x2013;1965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9187317</ArticleId><ArticleId IdType="pubmed">34390330</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, et al. . Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. The Lancet Resp Med. 2022 May 11;10(9):863&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Commission of the People's Republic of China . (2020 Feb 6). Handbook of prevention and treatment of the pneumonia caused by the novel coronavirus (2019-nCoV) (in Chinese). [Accessed Jul 2, 2020]. http://en.nhc.gov.cn/2020-02/06/c_76295.htm.</Citation></Reference><Reference><Citation>National Health Commission of the People's Republic of China . (2020 Mar 16). Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment. [Accessed July 2, 2020]. http://kjfy.meetingchina.org/msite/news/show/cn/3337.html</Citation></Reference><Reference><Citation>Pan F, Ye T, Sun P, et al. . Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 2020 Jun;295(3):715&#x2013;721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233367</ArticleId><ArticleId IdType="pubmed">32053470</ArticleId></ArticleIdList></Reference><Reference><Citation>Francone M, Iafrate F, Masci GM, et al. . Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020 Dec;30(12):6808&#x2013;6817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334627</ArticleId><ArticleId IdType="pubmed">32623505</ArticleId></ArticleIdList></Reference><Reference><Citation>Brightling CE, Evans RA.. Long COVID: which symptoms can be attributed to SARS-CoV-2 infection? Lancet. 2022 Aug 6;400(10350):411&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352303</ArticleId><ArticleId IdType="pubmed">35933996</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Scorza FA, Scorza CA, et al. . SARS-CoV-2 impairs vision. J Neuro-Ophthalmol. 2021 Jun 1;41(2):166&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">33999887</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. . Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022 Jan;22(1):43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, et al. . Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022 Jun 18;399(10343):2263&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Ding C, Yu L, et al. . One-year follow-up of chest CT findings in patients after SARS-CoV-2 infection. BMC Med. 2021 Aug 9;19(1):191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8349604</ArticleId><ArticleId IdType="pubmed">34365975</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Fan Y, Alwalid O, et al. . Fibrotic interstitial lung abnormalities at 1-year follow-up CT after severe COVID-19. Radiology. 2021 Dec;301(3):E438&#x2013;E440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8335811</ArticleId><ArticleId IdType="pubmed">34313470</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F, Yang L, Liang B, et al. . Chest CT patterns from diagnosis to 1 year of follow-up in patients with COVID-19. Radiology. 2022 Mar;302(3):709&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515211</ArticleId><ArticleId IdType="pubmed">34609153</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger AK, Sonnweber T, Gruber L, et al. . Chest CT of lung injury 1 year after COVID-19 pneumonia: The CovILD study. Radiology. 2022 Mar 29;304(2):462&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8988857</ArticleId><ArticleId IdType="pubmed">35348379</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberst G, Claude F, Laurent L, et al. . Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia. Ann Intensive Care. 2022 Mar 9;12(1):23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905558</ArticleId><ArticleId IdType="pubmed">35262794</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, Tonkin J, Devaraj A, et al. . CT lung abnormalities after COVID-19 at 3 months and 1 year after hospital discharge. Radiology. 2022 May;303(2):444&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515207</ArticleId><ArticleId IdType="pubmed">34609195</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchino M, Lieto R, Romano F, et al. . Chest CT-based assessment of 1-year outcomes after moderate COVID-19 pneumonia. Radiology. 2022 May 10;220019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9619196</ArticleId><ArticleId IdType="pubmed">35536134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravaglia C, Doglioni C, Chilosi M, et al. . Clinical, radiological, and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. Eur Respir J. 2022 Oct 6;60(4):2102411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8932282</ArticleId><ArticleId IdType="pubmed">35301248</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler SA, Ebner L, Aubry-Beigelman C, et al. . Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021 Apr 29;57(4):2003690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gassel RJJ, Bels JLM, Raafs A, et al. . High prevalence of pulmonary sequelae at 3 months after hospital discharge in mechanically ventilated survivors of COVID-19. Am J Respir Crit Care Med. 2021 Feb 1;203(3):371&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7874313</ArticleId><ArticleId IdType="pubmed">33326353</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso D, Guido G, Zerunian M, et al. . Post-Acute sequelae of COVID-19 pneumonia: Six-month chest CT follow-up. Radiology. 2021 Nov;301(2):E396&#x2013;E405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8335814</ArticleId><ArticleId IdType="pubmed">34313468</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med. 2021 Apr;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa GMJ, Lacerda SMSN, Figueiredo AFA, et al. . SARS-CoV-2 infects, replicates, elevates angiotensin II and activates immune cells in human testes. medRxiv. 2022.</Citation></Reference><Reference><Citation>Bowe B, Xie Y, Xu E, et al. . Kidney outcomes in long COVID. J Am Soc Nephrol. 2021 Nov;32(11):2851&#x2013;2862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao X, Li D, Ma Z, et al. . 12-Month Post-Discharge liver function test abnormalities Among patients With COVID-19: A single-center prospective cohort study. Front Cell Infect Microbiol. 2022;12:864933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046934</ArticleId><ArticleId IdType="pubmed">35493732</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P, Casari G, Townsend L, et al. . Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med. 2022 May;28(5):879&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022 Mar 3;185(5):881&#x2013;895.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, et al. . SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature. 2022 Apr;604(7907):697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. . Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. The Lancet Resp Med. 2021 Nov;9(11):1275&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Chen Y, Wang QH, et al. . One-Year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: A longitudinal cohort study. JAMA Neurol. 2022 May 1;79(5):509&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, et al. . Persistence of somatic symptoms after COVID-19 in The Netherlands: an observational cohort study. Lancet. 2022 Aug 6;400(10350):452&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>